{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:12:51Z","timestamp":1788955971587,"version":"build-2803163510"},"reference-count":21,"publisher":"National Academy of Sciences","issue":"37","license":[{"start":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000011","name":"Howard Hughes Medical Institute","doi-asserted-by":"publisher","award":["no number"],"award-info":[{"award-number":["no number"]}],"id":[{"id":"10.13039\/100000011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson\u2019s Research","doi-asserted-by":"publisher","award":["MJFF-027141"],"award-info":[{"award-number":["MJFF-027141"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.pnas.org"],"crossmark-restriction":true},"short-container-title":["Proc. Natl. Acad. Sci. U.S.A."],"published-print":{"date-parts":[[2026,9,15]]},"abstract":"<jats:p>This year\u2019s Lasker~Bloomberg Public Service Award honors the singular achievement of Michael J. Fox, who has devoted much of his life to a philanthropic effort to conquer Parkinson\u2019s Disease (PD), a progressive neurodegenerative disorder that afflicts many millions of patients world-wide. Just a few years after his diagnosis of PD at the tender age of 29, Fox pivoted in part from his enormous success in acting [leading roles in the Back to the Future trilogy (1985\u20131989) and in the hit National Broadcasting Corporation (NBC) sitcom Family Ties (1982\u20131989)] to the creation of the Michael J. Fox Foundation (MJFF). Fox\u2019s commitment and integrity have altered the landscape of inquiry into the clinical and basic science of PD and have helped to shape public policies and annually raise private ($400M) and government ($255M) support to find more effective treatments. In the 200 y since PD was first described, and despite recent decades of intense clinical work, only a few therapies have been developed to mitigate some aspects of the movement disorder. These treatments, especially the development of dopamine replacement and agonist drugs and the neurosurgical procedure of deep brain stimulation, have provided decades of limited symptom relief to millions of patients but no enduring therapies that alter the arc of progression of the disease. Now in the 4th decade of his personal battle with PD, Fox and the MJFF stand at the threshold of discoveries and clinical trials that show promise of therapies that go to the root causes of the disease.<\/jats:p>","DOI":"10.1073\/pnas.2622460123","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:00:21Z","timestamp":1788955221000},"update-policy":"https:\/\/doi.org\/10.1073\/pnas.cm10313","source":"Crossref","is-referenced-by-count":0,"title":["Lasker~Bloomberg Public Service Award to Michael J. Fox: The challenge of Parkinson\u2019s disease"],"prefix":"10.1073","volume":"123","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8615-6409","authenticated-orcid":false,"given":"Randy","family":"Schekman","sequence":"first","affiliation":[{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"HHMI, University of California Berkeley","place":["Berkeley"]},{"id":[{"id":"https:\/\/ror.org\/01an7q238","id-type":"ROR","asserted-by":"publisher"}],"name":"Department of Molecular and Cell Biology, University of California Berkeley","place":["Berkeley"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"341","published-online":{"date-parts":[[2026,9,9]]},"reference":[{"key":"e_1_3_4_1_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-080952"},{"key":"e_1_3_4_2_2","article-title":"Epidemiology of Parkinson\u2019s disease\u2014Global burden of disease research from 1990 to 2021 and future trend predictions","volume":"14","author":"Wang S.","year":"2026","unstructured":"S. Wang , Epidemiology of Parkinson\u2019s disease\u2014Global burden of disease research from 1990 to 2021 and future trend predictions. Clin. Park. Relat. Disord. 14, 100421 (2026).","journal-title":"Clin. Park. Relat. Disord."},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(19)30287-X"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.3233\/JPD-230357"},{"key":"e_1_3_4_5_2","unstructured":"N. Loeb Robin Williams and Lewy body dementia: What his story teaches us. Lewy Body Dementia Resource Center (2026). https:\/\/lewybodyresourcecenter.org\/robin-williams-lewy-body-dementia\/. Accessed 10 February 2026."},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00037"},{"key":"e_1_3_4_7_2","doi-asserted-by":"crossref","unstructured":"L. Concha-Marambio S. Proitzkow M. Shahnawaz C. M. Ferris Seed amplification assay for the detection of pathologic alpha-synuclein aggregates in cerebrospinal fluid. Nat. Protoc. 18 1179\u20131196 (2023).","DOI":"10.1038\/s41596-022-00787-3"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-021-01282-8"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.4103\/NRR.NRR-D-25-00380"},{"key":"e_1_3_4_10_2","first-page":"69","article-title":"\u03b1-synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease","volume":"19","author":"Geibl F. F.","year":"2024","unstructured":"F. F. Geibl , \u03b1-synuclein pathology disrupts mitochondrial function in dopaminergic and cholinergic neurons at-risk in Parkinson\u2019s disease. Mol. Degen. 19, 69 (2024).","journal-title":"Mol. Degen."},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-024-05262-8"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.neuron.2012.05.018"},{"key":"e_1_3_4_13_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2402206121"},{"key":"e_1_3_4_14_2","unstructured":"Parkinson\u2019s Foundation New report: In 2024 Parkinson\u2019s disease cost the U.S. $82.2 Billion surpassing previous projections. https:\/\/www.parkinson.org\/about-us\/news\/economic-burden-2024-report. Accessed 26 March 2026."},{"key":"e_1_3_4_15_2","doi-asserted-by":"crossref","unstructured":"R. Schekman E. Riley Point of view: Coordinating a new approach to Parkinson\u2019s disease (2019). https:\/\/elifesciences.org\/articles\/66546.","DOI":"10.7554\/eLife.51167"},{"key":"e_1_3_4_16_2","unstructured":"D. G. McNeil RFK Jr. mimics AIDS denier Thabo Mbeki. The Washington Post 3 April 2025. https:\/\/www.washingtonpost.com\/opinions\/2025\/04\/03\/kennedy-mbeki-aids-measles-denial\/. Accessed 30 July 2026."},{"key":"e_1_3_4_17_2","unstructured":"B. Zadrosy RFK Jr. comes home to his anti-vaccine group commits to a break for US infectious disease research. NBC News 23 November 2023. https:\/\/www.nbcnews.com\/politics\/politics-news\/rfk-jr-comes-home-anti-vaccine-group-commits-break-us-infectious-disea-rcna123551. Accessed 30 July 2026."},{"key":"e_1_3_4_18_2","unstructured":"J. Bonavitacola Vaccine skeptics among CDC vaccine panel replacements named by RFK. Jr. The American Journal of Managed Care 12 June 2025. https:\/\/www.ajmc.com\/view\/vaccine-skeptics-among-cdc-vaccine-panel-replacements-named-by-rfk-jr. Accessed 30 July 2026."},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.106702"},{"key":"e_1_3_4_20_2","unstructured":"Attain Partners Report on the indirect cost rates and recovery. https:\/\/www.aau.edu\/key-issues\/report-indirect-cost-rates-and-recovery. 20 January 2026."},{"key":"e_1_3_4_21_2","unstructured":"A. Oza Trump administration pursues more durable changes to science policy after setbacks in court. STAT News 8 July 2026. https:\/\/www.statnews.com\/2026\/07\/08\/trump-research-funding-scientists-see-omb-overreach-control. Accessed 30 July 2026."}],"container-title":["Proceedings of the National Academy of Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pnas.org\/doi\/pdf\/10.1073\/pnas.2622460123","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:00:40Z","timestamp":1788955240000},"score":1,"resource":{"primary":{"URL":"https:\/\/pnas.org\/doi\/10.1073\/pnas.2622460123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,9]]},"references-count":21,"journal-issue":{"issue":"37","published-print":{"date-parts":[[2026,9,15]]}},"alternative-id":["10.1073\/pnas.2622460123"],"URL":"https:\/\/doi.org\/10.1073\/pnas.2622460123","relation":{},"ISSN":["0027-8424","1091-6490"],"issn-type":[{"value":"0027-8424","type":"print"},{"value":"1091-6490","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,9]]},"assertion":[{"value":"2026-09-09","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e2622460123"}}